Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency

NCT00542997 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00542997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00542997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
August 31, 2009
Enrollment
51 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive agammaglobulinemia, common variable immunodeficiency, x-linked agammaglobulinemia